CJC-1295 (No DAC) + Ipamorelin Peptide Blend – Research Use Only
 
Description:
This peptide blend combines CJC-1295 without DAC, a growth hormone–releasing hormone (GHRH) analogue, with Ipamorelin, a selective growth hormone secretagogue (GHS). Both have been studied for their ability to stimulate endogenous growth hormone (GH) release, and when used together, they are of interest in research for potential synergistic effects on growth hormone pulsatility, IGF-1 expression, and cellular repair pathways.
 
Background:
CJC-1295 (without DAC) is a tetrasubstituted GHRH analogue designed to increase growth hormone release with a shorter half-life than its DAC-modified counterpart, making it suitable for studying natural GH pulsation.
Ipamorelin is a pentapeptide ghrelin mimetic that selectively stimulates GH release without significantly affecting cortisol or prolactin, making it a targeted tool for endocrine and regenerative research.
When combined, this blend has been studied for its ability to enhance growth hormone secretion patterns, supporting research in muscle physiology, metabolism, and cellular recovery models.
 
Potential Areas of Research:
Growth hormone pulsatility and IGF-1 regulation
Muscle tissue, protein synthesis, and recovery studies
Metabolic research models involving fat utilization and glucose regulation
Comparative studies of single vs. combination GH secretagogues
Endocrine system signaling pathways
 
Molecular Formula & Weight:
CJC-1295 (without DAC): C₁₅₂H₂₅₂N₄₄O₄₂ | ~3367 g/mol
Ipamorelin: C₃₈H₄₉N₉O₅ | ~711.9 g/mol
 
Disclaimer:
This peptide blend is provided strictly for laboratory research purposes only. It is not a drug, food, or cosmetic, and must not be misused for human consumption, medical, or veterinary applications.